Effect of Ottoman Viper (Montivipera xanthina (Gray, 1849)) Venom on Various Cancer Cells and on Microorganisms

Cytotechnology

Volumn 66, Issue 1, 2014, Pages 87-94

  Yalcın, Husniye Tansel ^a   Ozen, Mehmet Ozgün ^b   Gocmen, Bayram ^a   Nalbantsoy, Ayse ^b  

^a EGE UNIVERSITY   (Turkey)

^b EGE UNIVERSITY   (Turkey)

Author keywords

Antimicrobial activity; Cytotoxicity; Montivipera xanthina; Snake venom; Viper

Indexed keywords

AMPICILLIN; NYSTATIN; VIPER VENOM;

ANTIBACTERIAL ACTIVITY; ANTIFUNGAL ACTIVITY; ANTINEOPLASTIC ACTIVITY; ARTICLE; BACILLUS CEREUS; CANCER CELL CULTURE; CANDIDA ALBICANS; CELL STRAIN HEP3B; CELL STRAIN HT29; CELL STRAIN LNCAP; CELL STRAIN MCF 7; CELL STRAIN SAOS 2; CELL VIABILITY; CONTROLLED STUDY; DRUG POTENCY; ENTEROCOCCUS FAECALIS; ENTEROCOCCUS FAECIUM; ESCHERICHIA COLI; HUMAN; HUMAN CELL; IC 50; IN VITRO STUDY; MINIMUM BACTERICIDAL CONCENTRATION; MINIMUM INHIBITORY CONCENTRATION; MONTIVIPERA XANTHINA; NONHUMAN; POISONOUS SNAKE; PROTEUS VULGARIS; SALMONELLA TYPHIMURIUM; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS EPIDERMIDIS; VERO CELL;

BACTERIA (MICROORGANISMS); CANDIDA ALBICANS; ENTEROCOCCUS FAECALIS; ENTEROCOCCUS FAECIUM; ESCHERICHIA COLI; PROTEUS VULGARIS; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS EPIDERMIDIS ATCC 12228; VIPERINAE; XANTHINA;

EID: 84893704490     PISSN: 09209069     EISSN: 15730778     Source Type: Journal    
DOI: 10.1007/s10616-013-9540-z     Document Type: Article

References (32)

1. Ahmadi AJ, Fathi B, Jamshidi A, Zolfagharian H, Mirakabbadi AZ (2010) Investigation of the antibacterial effect of venom of the Iranian Snake Echis carinatus. Iran J Vet Sci Technol 2:93-100
2. Arikan H, Göçmen B, Mermer A, Bahar H (2005) An electrophoretic comparison of the venoms of a colubrid and various viperid snakes from Turkey and Cyprus, with some taxonomic and phylogenetic implications. Zootaxa 1038:1-10
3. Bastos MLA, Lima MRF, Conserva LM, Andrade VS, Rocha EMM, Lemos RPL (2009) Studies on the antimicrobial activity and brine shrimp toxicity of Zeyheria tuberculosa (Vell.) Bur. (Bignoniaceae) extracts and their main constituents. Ann Clin Microbiol Antimicrob 8:1-6
4. Bauer AW, Kirby WM, Sherris JC, Turck M (1966) Antibiotic susceptibility testing by a standardized single disk method. Am J Clin Pathol 45:493-496
5. Bradford MM (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248-254
6. Braganca BM, Hospattankar AV (1978) Potentiating Action of Cobra venom cytotoxin on the antitumour effects of alkylating agents (Melphalan). Eur J Cancer 14:707-712
7. Bustillo L, Leiva LC, Merino L, Acosta O, Joffé EBdK, Gorodner OJ (2008) Antimicrobial activity of Bothrops alternatus venom from the Northeast of Argentine. Rev Latinoam Microbiol 50:79-82
8. Chellapandi P, Jebakumar SRD (2008) Purification and antibacterial activity of Indian Cobra and Viper Venoms. eJBio 4:11-16
9. Davis HL, Ramirez G, Ellerby RA, Ansfield FJ (1974) Five-drug therapy in advanced breast cancer. Factors Influencing Toxicity and Response. Cancer 34:239-245
10. Francis S, Markland A (2001) Novel Snake venom disintegrin that inhibits human ovarian cancer dissemination and angiogenesis in an orthotopic nude mouse model. Haemostasis 31:183-191
11. Göçmen B, ArIkan H, Mermer A, Langerwerf B, Bahar H (2006) Morphological, hemipenial and venom electrophoresis comparisons of Levantine Viper, Macrovipera lebetina (Linnaeus, 1758) from Cyprus and Southern Anatolia. Turk J Zool 30:225-234
12. Jamunaa A, Vejayan J, Halijah I, Sharifah SH, Ambu S (2012) Cytotoxicity of Southeast Asian snake venoms. J Venom Anim Toxins incl Trop Dis 18:150-156
13. Kaufmann SH, Vaux DL (2003) Alterations in the apoptotic machinery and their potential role in anticancer drug resistance. Oncogene 22:7414-7430
14. Koh DC, Armugam A, Jeyaseelan K (2006) Snake venom components and their applications in biomedicine. Cell Mol Life Sci 63:3030-3041
15. Macht DI (1940) New developments in pharmacology and therapeutics of cobra venom. Trans Am Ther Soc 40:62
16. Mishra NN, Prasad T, Sharma N, Paysi A, Prasad R, Gupta DK, Singh R (2007) Pathogenicity and drug resistance in Candida albicans and other yeast species. A review. Acta Microbiol Immunol Hung 54:201-235
17. Mosmann T (1983) Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 65:55-63
18. Nair DG, Fry BG, Alewood P, Prakash P, Kumar PP, Kini RM (2007) Antimicrobial activity of omwaprin, a new member of the waprin family of snake venom proteins. Biochem. J 402:93-104
19. Nalbantsoy A, Karabay-Yavasoglu NU, SayIm F, Deliloglu-Gurhan I, Gocmen B, ArIkan H, Yildiz MZ (2012) Determination of in vivo toxicity and in vitro cytotoxicity of venom from the Cypriot blunt-nosed viper Macrovipera lebetina lebetina and antivenom production. J Venom Anim Toxins incl Trop Dis 18:208-216
20. NCCLS (2009) Performance standards for antimicrobial susceptibility testing, nineteenth informational supplement. Approved Standard M100-S19 National Committee for Clinical Standards. Wayne PA January
21. Pal SK, Gomes A, Dasgupta SC, Gomes A (2002) Snake venom as therapeutic agents: from toxin to drug development. Indian J Exp Biol 40:1353-1358
22. Samel M, Trummal K, Siigur E, Siigur J (2012) Effect of HUVEC apoptosis inducing proteinase from Vipera lebetina venom (VLAIP) on viability of cancer cells and on platelet aggregation. Toxicon 60:648-655
23. Samy RP, Pachiappan A, Gopalakrishnakone P, Thwin MM, Hian YE, Chow VTK, Bow H, Weng JT (2006) In vitro antimicrobial activity of natural toxins and animal venoms tested against Burkholderia pseudomallei. BMC Infect Dis 6:1-16
24. Samy RP, Gopalakrishnakone P, Thwin MM, Chow TKV, Bow H, Yap EH, Thong TWJ (2007) Antibacterial activity of snake, scorpion and bee venoms: a comparison with purified venom phospholipase A2 enzymes. J Appl Microbiol 102:650-659
25. San TM, Vejayan J, Shanmugan K, Ibrahim H (2010) Screening antimicrobial activity of venoms from snakes commonly found in Malasia. J Appl Sci 10:2328-2332
26. Shebl RI, Mohamed AF, Ali AE, Amin MA (2012) Cerastes cerastes and Vipera lebetina Snake Venoms apoptotic - stimulating activity to human breast cancer cells and related gene modulation. J Cancer Sci Ther 4:317-323
27. Swenson S, Costa F, Minea R, Sherwin RP, Ernst W, Fujii G, Yang D, Markland FS Jr (2004) Intravenous liposomal delivery of the snake venom disintegrin contortrostatin limits breast cancer progression. Mol Cancer Ther 3:499-511
28. Tare TG, Sutar NK, Renapurkar DM (1986) A study of snake venom yield by different methods of venom extraction. Amphib Reptile 7:187-191
29. Wilson TR, Johnston PG, Longley DB (2009) Anti-apoptotic mechanisms of drug resistance in cancer. Curr Cancer Drug Targets 9:307-319
30. Zare MA, Mahdavi S, Koohi MK, Taghavian M (2008) Cytotoxic effect of ICD-85 (venom- derived peptides) on MDA-MB-231 cell line. J Venom Anim Toxins incl Trop Dis 14:180-186
31. Zhou Q, Nakada MT, Arnold C, Markland FS (1999) Contortrostatin, a dimeric disintegrin from Agkistrodon contortrix contortrix, inbibits angiogenesis. Angiogenesis 3:259-269
32. Zhou Q, Wulfkuhle J, Ouatas T, Fukushima P, Stetler-Stevenson M, Miller FR, Steeg PS (2000) Contortrostatin, a dimeric disintegrin from agkistrodo contortrix, inbibit s breast cancer progression. Breast Cancer Res Treat 61:249-260